Schneider Andrew E, Johnson Jonathan N, Taggart Nathaniel W, Cabalka Allison K, Hagler Donald J, Reeder Guy S, Cetta Frank
Department of Pediatrics, Mayo Clinic, Rochester, Minn, USA.
Congenit Heart Dis. 2014 May-Jun;9(3):228-34. doi: 10.1111/chd.12130. Epub 2013 Aug 15.
Percutaneous coronary intervention (PCI) is commonly used in adult patients with coronary artery disease, but data on PCI in children and adolescents remain limited. Herein, we describe our experience with the use of PCI in pediatric and adolescent patients.
This is a retrospective review.
The study was conducted at Mayo Clinic, Rochester, MN.
All patients ≤18 years old who underwent PCI from 2004 to 2012 were included.
Intravascular ultrasound and balloon angioplasty were performed in all patients, with subsequent stent placement in 6/7 (86%) procedures.
Residual postintervention stenosis, early procedural morbidity and mortality were the outcome measures.
Overall, seven unique PCI procedures were performed in five patients (four males, mean age 13.2 ± 3.8 years, range 8-18 years). Mean follow-up interval was 2 (0.6-5.5) years. Indications for the procedures included transplant coronary vasculopathy (n = 1), coronary dissection (n = 1), and acute coronary thrombosis/myocardial infarction (n = 1). Additionally, there were two patients (n = 2) who experienced coronary compression as a sequelae of prior heart surgery. Intravascular ultrasound and balloon angioplasty were performed in all patients, with subsequent stent placement in 6/7 (86%) procedures. A total of eight stents were placed (average stent diameter 3 ± 0.5 mm), including six (75%) drug-eluting stents. The targeted coronary artery lesions were successfully treated in all seven procedures. There was no early procedural morbidity or mortality. Two patients were noted to have angiographic evidence of in-stent restenosis at 3 and 15 months postdeployment, respectively, despite treatment with aspirin and clopidogrel.
PCI in children and adolescents can be utilized to improve coronary blood flow in a variety of clinical situations. It may be particularly effective in cases of postsurgical coronary compression. Close angiographic follow-up is critical as these patients are at risk for in-stent restenosis.
经皮冠状动脉介入治疗(PCI)常用于成年冠心病患者,但儿童和青少年患者PCI的数据仍然有限。在此,我们描述我们在儿科和青少年患者中使用PCI的经验。
这是一项回顾性研究。
该研究在明尼苏达州罗切斯特市的梅奥诊所进行。
纳入了2004年至2012年期间接受PCI的所有18岁及以下患者。
所有患者均进行血管内超声检查和球囊血管成形术,随后在7例手术中的6例(86%)中进行支架置入。
干预后残余狭窄、早期手术并发症和死亡率为观察指标。
总体而言,对5例患者(4例男性,平均年龄13.2±3.8岁,范围8 - 18岁)进行了7例独特的PCI手术。平均随访间隔为2(0.6 - 5.5)年。手术指征包括移植冠状动脉病变(n = 1)、冠状动脉夹层(n = 1)和急性冠状动脉血栓形成/心肌梗死(n = 1)。此外,有2例患者(n = 2)因既往心脏手术出现冠状动脉受压后遗症。所有患者均进行血管内超声检查和球囊血管成形术,随后在7例手术中的6例(86%)中进行支架置入。共置入8枚支架(平均支架直径3±0.5毫米),其中6枚(75%)为药物洗脱支架。所有7例手术中目标冠状动脉病变均得到成功治疗。无早期手术并发症或死亡。尽管使用了阿司匹林和氯吡格雷治疗,但分别有2例患者在支架置入后3个月和15个月出现支架内再狭窄的血管造影证据。
儿童和青少年患者的PCI可用于改善多种临床情况下的冠状动脉血流。在术后冠状动脉受压的情况下可能特别有效。由于这些患者有支架内再狭窄的风险,密切的血管造影随访至关重要。